Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Net Margin (2016 - 2025)

Bio-Techne has reported Net Margin over the past 17 years, most recently at 12.85% for Q4 2025.

  • Quarterly results put Net Margin at 12.85% for Q4 2025, up 110.0% from a year ago — trailing twelve months through Dec 2025 was 0.47% (down 1278.0% YoY), and the annual figure for FY2025 was 1.1%, down 1466.0%.
  • Net Margin for Q4 2025 was 12.85% at Bio-Techne, down from 13.33% in the prior quarter.
  • Over the last five years, Net Margin for TECH hit a ceiling of 4486.7% in Q3 2022 and a floor of 67.03% in Q2 2022.
  • Median Net Margin over the past 5 years was 14.24% (2023), compared with a mean of 231.13%.
  • Biggest five-year swings in Net Margin: surged 445993bps in 2022 and later crashed -446829bps in 2023.
  • Bio-Techne's Net Margin stood at 26.76% in 2021, then plummeted by -31bps to 18.41% in 2022, then tumbled by -45bps to 10.08% in 2023, then rose by 17bps to 11.75% in 2024, then increased by 9bps to 12.85% in 2025.
  • The last three reported values for Net Margin were 12.85% (Q4 2025), 13.33% (Q3 2025), and 32.97% (Q2 2025) per Business Quant data.